HDACis can improve the function of pancreatic β cells, promote insulin synthesis and release, reduce inflammatory response-induced damage to pancreatic β cells, regulate the influence of the systemic immune response on T1DM and T2DM, and ameliorate the complications of diabetes (Sharma and Taliyan, 2016a). The gene discussed is INS; the disease is type 2 diabetes mellitus.